medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2019, Number 2

<< Back Next >>

Acta Pediatr Mex 2019; 40 (2)

Epidemiological overview of rotaviral gastroenteritis and prevalence of intussusception in Mexico

Gómez-Altamirano CM, Carrión-Falcón V

Language: Spanish
References: 26
Page: 59-64
PDF size: 328.47 Kb.


ABSTRACT

Objective: To describe the predominant genotypes of rotavirus and the cases of hospitalizations due to intussusception in children under one year of age, based on data published by the National Health Information System (2000-2015).
Materials and Methods: Observational, retrospective and analytical study carried out based on information from the Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE) to determine circulating rotavirus genotypes. The cases of intestinal intussusception in children under one year were obtained from the dynamic cubes of the Dirección General de Información en Salud, Secretaría de Salud.
Results:In the period analyzed, there was predominance of the G1 genotype, especially in 2000-2005. In different years other strains predominated: G2 in 2006, 2011 and 2012, G3 in 2008 and 2009 and, in addition, G9 in 2010. The G12 strains were the predominant ones from 2013. The cases of annual rotavirus hospitalization were: 522 in 2004 and 273 in 2012, with a peak of 1071 in 2007. In 2011, the maximum number of reported cases (n = 1037) of intussusception was reached, with a downward trend since then.
Conclusions: The circulating rotavirus genotypes in Mexico have variability. During the studied period hospital discharges of patients diagnosed with intestinal intussusception decreased. The number of these cases reported in Mexico decreased compared to that registered in the official databases of previous years.


REFERENCES

  1. World Health Organization. Diarrhoea [Internet] 2016 [consultado: 17 mayo 2016]. http://www.who.int/topics/ diarrhoea/

  2. Forster J, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics. 2009 Mar; 123(3):e393-400. doi: 10.1542/peds.2008-2088

  3. O'Ryan M. Rotarix (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines. 2007; 6(1):11-9. https://doi. org/10.1586/14760584.6.1.11

  4. Gómez F, et al. Cambio en los patrones de los genotipos de rotavirus en México hacia el genotipo emergente G12P [8] durante 2012-2013. XIII Biomedicine and Molecular Biotechnology Scientific Meetings, 2015.

  5. Albano F, et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr. 2007 Mar; 166(3):241-7. https://doi.org/10.1007/ s00431-006-0237-6

  6. Parashar UD, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006 Feb; 12(2):304-6. doi: 10.3201/ eid1202.050006

  7. De Rougemont A, et al. Molecular and clinical characterization of rotavirus from diarrheal infants admitted to pediatric emergency units in France. Pediatr Infect Dis J. 2011 Feb; 30(2):118-24. doi: 10.1097/INF.0b013e3181ef034e

  8. Palumbo E, Branchi M, Malorgio C, Siani A, Bonora G. Diarrhea in children: etiology and clinical aspects. Minerva Pediatr. 2010 Aug; 62(4):347-51.

  9. Dennehy PH. Viral Gastroenteritis in Children. The Pediatric Infectious Disease Journal. 2011; 30(1):63-4.

  10. Sanchez-Uribe E, et al. Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization. Clin Infect Dis. 2016; 62 Suppl 2:S133-9.

  11. Aranda CA, Lozano HG, Fernández MAL, Ramírez HLG. Genotipos de rotavirus asociados con la enfermedad diarreica aguda (EDA) en México. Gaceta Epidemiológica. 2011; Año1, No.2.

  12. Rodriguez Castillo A, et al. VP4 and VP7 genotyping by reverse transcription-PCR of human rotavirus in mexican children with acute diarrhea. J Clin Microbiol. 2000 Oct; 38(10):3876-8.

  13. Garcia-Lozano H, López-Martínez I, Carrión-Falcón V, Villaseñor-Ruíz I, Gómez-Altamirano M, Perez-Bolde C, et al. Incidencia de genotipos de rotavirus asociados a enfermedad diarreica. Reunión Anual de Salud Pública, Mérica, Yucatán 2014.

  14. Quintas I. Modelo aditivo generalizado GAM: Regresión no lineal y no paramétrica. 2000. ISBN: 978-607-28-0154-7 80-9.

  15. Reyna-Figueroa J, Sánchez-Uribe E, Esteves-Jaramillo A, Hernández-Hernández LC, Richardson V. Enfermedad diarreica por rotavirus en brotes epidémicos. Rev Panam Salud Pública. 2012; 31(2):142-7.

  16. Velasquez D, et al. Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: An overview. Infection, Genetics and Evolution 2014;28: 561-71. http:// dx.doi.org/10.1016/j.meegid.2014.10.008

  17. Leshem E, et al. Distribution of rotavirus strains and strainspecific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14: 847-56. https://doi.org/10.1016/ S1473-3099(14)70832-1

  18. de Oliveira, et al. Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis. Vaccine 2015;33: A248-54. https://doi. org/10.1016/j.vaccine.2014.11.060

  19. Santos VS, et al. Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis, Infect Dis Poverty. 2016; 5:83. doi 10.1186/s40249-016-0173-2

  20. Yen C, Healy K, Tate JE, Parashar UD, Bines J, Neuzil K, et al. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries. Hum Vaccin Immunother. 2016; 12(10):2580-9.

  21. Mpabalwani EM, et al. Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization. Journal of Tropical Pediatrics 2017;63: 221-28. https://doi.org/10.1093/ tropej/fmw069

  22. Mushen K, et al. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011e2015: a cases control study. Clin Microbiol Infection 2018;24(1):53-59. http://dx.doi.org/10.1016/j. cmi.2017.04.018

  23. Martinón-Torres F, et al. Safety, Tolerability and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process. Pediatr Infect Dis J 2017; 36:417-22. https://doi.org/10.1097/INF.0000000000001511

  24. Velazquez RF, et al. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and metaanalysis for Latin America and the Caribbean. BMC Pediatrics. 2017 (https://doi.org/10.1186/s12887-016-0771-y

  25. Kirkwood CD, et al. The rotavirus vaccine development pipeline. Vaccine 2017. https://doi.org/10.1016/j.vaccine. 2017.03.076

  26. Kotirum S. Global economic evaluations of rotavirus vaccines: A systematic review. Vaccine 2017;35 (2017) 3364-86. https://doi.org/10.1016/j.vaccine.2017.04.051




2020     |     www.medigraphic.com